Cargando…
P38 MAPK and glucocorticoid receptor crosstalk in bronchial epithelial cells
ABSTRACT: p38 MAPK inhibition may have additive and synergistic anti-inflammatory effects when used with corticosteroids. We investigated crosstalk between p38 MAPK inhibitors and corticosteroids in bronchial epithelial cells to investigate synergistic effects on cytokine production and the molecula...
Autores principales: | Lea, Simon, Li, Jian, Plumb, Jonathan, Gaffey, Kate, Mason, Sarah, Gaskell, Rosie, Harbron, Chris, Singh, Dave |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7080672/ https://www.ncbi.nlm.nih.gov/pubmed/31974640 http://dx.doi.org/10.1007/s00109-020-01873-3 |
Ejemplares similares
-
Crosstalk between p38 MAPK and GR Signaling
por: Zeyen, Lisa, et al.
Publicado: (2022) -
Oral and inhaled p38 MAPK inhibitors: effects on inhaled LPS challenge in healthy subjects
por: Singh, Dave, et al.
Publicado: (2015) -
Mechanism of p38 MAPK–induced EGFR endocytosis and its crosstalk with ligand-induced pathways
por: Perez Verdaguer, Mireia, et al.
Publicado: (2021) -
Evaluation of Glucocorticoid Receptor Function in COPD Lung Macrophages Using Beclomethasone-17-Monopropionate
por: Plumb, Jonathan, et al.
Publicado: (2013) -
Glucocorticoid receptor expression in human bronchial epithelial cells: effects of smoking and COPD.
por: Verheggen, M M, et al.
Publicado: (1998)